Innovotech Inc (IOT) - Total Liabilities

Latest as of March 2026: CA$1.05 Million CAD ≈ $761.53K USD

Based on the latest financial reports, Innovotech Inc (IOT) has total liabilities worth CA$1.05 Million CAD (≈ $761.53K USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Innovotech Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.

Innovotech Inc - Total Liabilities Trend (2003–2025)

This chart illustrates how Innovotech Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Innovotech Inc total assets.

Innovotech Inc Competitors by Total Liabilities

The table below lists competitors of Innovotech Inc ranked by their total liabilities.

Company Country Total Liabilities
Haffner Energy SA
PA:ALHAF
France €14.12 Million
Albion Technology & General VCT PLC
LSE:AATG
UK GBX1.81 Million
NEOMETALS LTD SP.ADS/10
F:9R91
Germany €6.10 Million
Forza X1 Inc
NASDAQ:FRZA
USA $180.87K
Golden Goliath Resources Ltd.
V:GNG
Canada CA$389.98K
TRU PRECIOUS METALS CORP.
F:706
Germany €1.95 Million
CubicFarm Systems Corp
V:CUB
Canada CA$41.14 Million
GLOBAL UAV TECHS
F:YAB
Germany €1.48 Million

Liability Composition Analysis (2003–2025)

This chart breaks down Innovotech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Innovotech Inc net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.28 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.33 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.24 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Innovotech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Innovotech Inc (2003–2025)

The table below shows the annual total liabilities of Innovotech Inc from 2003 to 2025.

Year Total Liabilities Change
2025-12-31 CA$784.68K
≈ $567.62K
+31.48%
2024-12-31 CA$596.80K
≈ $431.72K
+173.85%
2023-12-31 CA$217.93K
≈ $157.65K
+31.84%
2022-12-31 CA$165.29K
≈ $119.57K
-35.44%
2021-12-31 CA$256.04K
≈ $185.22K
+44.28%
2020-12-31 CA$177.46K
≈ $128.37K
+0.38%
2019-12-31 CA$176.79K
≈ $127.89K
-1.15%
2018-12-31 CA$178.86K
≈ $129.38K
-48.27%
2017-12-31 CA$345.76K
≈ $250.12K
-77.60%
2016-12-31 CA$1.54 Million
≈ $1.12 Million
+26.95%
2015-12-31 CA$1.22 Million
≈ $879.64K
+3.53%
2014-12-31 CA$1.17 Million
≈ $849.63K
+18.33%
2013-12-31 CA$992.54K
≈ $717.99K
+56454.93%
2003-12-31 CA$1.75K
≈ $1.27K
-95.64%
2003-09-30 CA$40.22K
≈ $29.10K
--

About Innovotech Inc

V:IOT Canada Biotechnology
Market Cap
$3.15 Million
CA$4.36 Million CAD
Market Cap Rank
#29482 Global
#1389 in Canada
Share Price
CA$0.08
Change (1 day)
+6.67%
52-Week Range
CA$0.07 - CA$0.29
All Time High
CA$0.34
About

Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assa… Read more